|
Tumor Heterogeneity in Advanced Metastatic Prostate Cancer; Challenges and Opportunities |
10/07/2022 - 12:00pm to 1:00pm EDT |
|
Deciphering the Anti-oncogenic Effects of Classical Oncoproteins in Liver Cancer |
10/14/2022 - 12:00pm to 1:00pm EDT |
|
Immune Checkpoint Blockade in Glioblastoma: Current Understanding and Future Directions |
10/21/2022 - 12:00pm to 1:00pm EDT |
|
It Just Doesn’t Happen. Or Does It? A Question of TP53 Mutation in Infantile SHH-Activated Medulloblastoma |
10/28/2022 - 12:00pm to 1:00pm EDT |
|
Current Topics in Pathology |
11/04/2022 - 12:00pm to 1:00pm EDT |
|
Tumor Immune Microenvironment Associates With Treatment Response to Immune Checkpoint Therapy (ICT) in Mesothelioma |
11/11/2022 - 12:00pm to 1:00pm EST |
|
Current Topics in Pathology |
11/16/2022 - 12:00pm to 1:00pm EST |
|
Pathologist-Performed USFNA of the Thyroid and the Imperfections of Bethesda Category III |
11/18/2022 - 12:00pm to 1:00pm EST |
|
Current Topics in Pathology |
11/23/2022 - 12:00pm to 1:00pm EST |
|
Current Topics in Pathology |
12/02/2022 - 12:00pm to 1:00pm EST |
Facebook
Twitter
LinkedIn
Forward